By Pat Anson, Editor
The Food and Drug Administration has informed a British pharmaceutical company that it will not stop other drug makers from producing generic versions of Suboxone tablets, one of its top selling products. The move is a serious blow to Reckitt Benckiser’s efforts to maintain its monopoly of Suboxone, which generates sales of about $1.5 billion annually.
Two New Jersey based generic drug makers said they had obtained FDA approval and would immediately begin selling generic versions of buprenorphine, which is more widely known as Suboxone. The drug is increasingly being used to treat addiction to heroin and opioid painkillers such as Vicodin and OxyContin.
Read more at National Pain Report.
Pain Patients Speak Out at California Forum
May 19, 2013
When Words Can Hurt
May 17, 2013
Painkillers Linked to Erectile Dysfunction
May 16, 2013
My Story: Fighting RSD With My Family
May 16, 2013
Attorneys General Ask for New Opioids Warning
May 15, 2013
Chronic Pain is Manageable
May 13, 2013
Life in Pain: Work Comp
May 13, 2013
Antibiotics May Help Back Pain
May 10, 2013
New Guidelines for Treating Fibromyalgia in Canada
May 10, 2013
No Decision on Zohydro Until Summer
May 10, 2013Share
About Author
(0) Readers Comments
More movement, less pain.
Click Image to go to National Pain Report
Marijuana’s Link to Schizophrenia Debated
This article just simply wrote out in scientific terms the effects of
Antibiotics May Help Back Pain
Interesting read and look forward to further information, seems a very
Do Nutraceuticals Help Chronic Pain Sufferers?
Thanks for sharing information regarding joint pain, It would be more
FDA Delays Approval of Suboxone Implant
"Surprised and disappointed" that the FDA doesn't want to rush yet ano
Do Nutraceuticals Help Chronic Pain Sufferers?
I agree with the comment regarding use of fish oil for OA, but would g
